Longitudinal Associations Between Cannabis Use and Cognitive Impairment in a Clinical Sample of Middle-Aged Adults Using Cannabis for Medical Symptoms
Cannabis and Cannabinoid Research · 2024
DOI: 10.1089/can.2022.0310 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cannabis and Cannabinoid Research, 2024. Verfasst von Ofir Livne und 3 weiteren Autor:innen. Beteiligte Einrichtung: New York State Psychiatric Institute, New York, New York, USA. Hauptthemen laut MEDLINE: Cognitive Dysfunction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- New York State Psychiatric Institute, New York, New York, USA.
- Department of Psychiatry, Massachusetts General Hospital (MGH), Boston, Massachusetts, USA.
- Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Ofir Livne, Jodi M Gilman
Förderung
- NIDA NIH HHS
Zitieren
APA
Livne, O., Potter, K. W., Schuster, R. M., & Gilman, J. M. (2024). Longitudinal Associations Between Cannabis Use and Cognitive Impairment in a Clinical Sample of Middle-Aged Adults Using Cannabis for Medical Symptoms. Cannabis and Cannabinoid Research. https://doi.org/10.1089/can.2022.0310
Vancouver
Livne O, Potter KW, Schuster RM, Gilman JM. Longitudinal Associations Between Cannabis Use and Cognitive Impairment in a Clinical Sample of Middle-Aged Adults Using Cannabis for Medical Symptoms. Cannabis and Cannabinoid Research. 2024. doi:10.1089/can.2022.0310
BibTeX
@article{Livne2024,
author = {Livne, Ofir and Potter, Kevin W and Schuster, Randi M and Gilman, Jodi M},
title = {Longitudinal Associations Between Cannabis Use and Cognitive Impairment in a Clinical Sample of Middle-Aged Adults Using Cannabis for Medical Symptoms},
journal = {Cannabis and Cannabinoid Research},
year = {2024},
doi = {10.1089/can.2022.0310}
}
EUVIMED